AC
BHVN
Armistice Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-524,000
| Closed | -$62.1M | – | 215 |
|
|
2022
Q1 | $62.1M | Buy |
524,000
+56,000
| +12% | +$6.64M | 1.2% | 19 |
|
|
2021
Q4 | $64.5M | Buy |
468,000
+92,000
| +24% | +$12.7M | 1.06% | 22 |
|
|
2021
Q3 | $52.2M | Sell |
376,000
-124,000
| -25% | -$17.2M | 0.88% | 26 |
|
|
2021
Q2 | $48.5M | Sell |
500,000
-500,000
| -50% | -$48.5M | 0.87% | 28 |
|
|
2021
Q1 | $68.4M | Buy |
1,000,000
+428,000
| +75% | +$29.3M | 1.57% | 12 |
|
|
2020
Q4 | $49M | Sell |
572,000
-328,000
| -36% | -$28.1M | 1.67% | 12 |
|
|
2020
Q3 | $58.5M | Buy |
900,000
+400,000
| +80% | +$26M | 2.12% | 7 |
|
|
2020
Q2 | $36.6M | Sell |
500,000
-556,000
| -53% | -$40.6M | 1.6% | 15 |
|
|
2020
Q1 | $35.9M | Buy |
1,056,000
+444,000
| +73% | +$15.1M | 2.22% | 11 |
|
|
2019
Q4 | $33.3M | Buy |
612,000
+34,000
| +6% | +$1.85M | 1.92% | 8 |
|
|
2019
Q3 | $24.1M | Buy |
578,000
+418,000
| +261% | +$17.4M | 1.6% | 21 |
|
|
2019
Q2 | $7.01M | Buy |
+160,000
| New | +$7.01M | 0.44% | 40 |
|